Literature DB >> 29404179

A Prospective Review of the Results of Patients Treated and Followed up for a Diagnosis of Sarcoidosis.

Levent Özdemir1, Burcu Özdemir2.   

Abstract

OBJECTIVES: The present study reports the treatment and follow-up results of patients prospectively diagnosed and treated in a public hospital.
MATERIAL AND METHODS: The present study reports the prospective follow-up data of 21 sarcoidosis cases followed up and treated in the Department of Chest Diseases of Dörtyol State Hospital from January 2010 to December 2014.
RESULTS: The 21 cases had a mean age of 44±10 years and a mean follow-up period of 38±13 months. While 10 cases were given steroid treatment, 11 cases were radiologically followed up. Besides pulmonary involvement, skin findings were detected in 7 cases and ophthalmologic findings were detected in 3 cases. In the treatment group, regression was observed in the radiographic findings of 6 cases, while no radiologically significant changes were seen in 4 cases. In the follow-up group, regression was observed in the radiographic findings of 9 cases, while no significant changes were seen in mediastinal LAPs of 2 cases. At the end of the treatment, it was found that 1 case developed steroid-induced myopathy, 1 case developed fungus ball of the sequelae, 1 case had loss of vision secondary to posterior uveitis, and 1 case had a risk of steroid-induced osteoporosis.
CONCLUSION: Choice of treatment procedure based on the stage and clinical results of the patient is still the most effective method in sarcoidosis treatment.

Entities:  

Keywords:  Sarcoidosis; diagnosis; treated

Year:  2017        PMID: 29404179      PMCID: PMC5783047          DOI: 10.5152/TurkThoracJ.2017.17028

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  8 in total

1.  An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment.

Authors:  M A Judson
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

Review 2.  Treatment of sarcoidosis.

Authors:  Christopher S King; William Kelly
Journal:  Dis Mon       Date:  2009-11       Impact factor: 3.800

3.  Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group.

Authors:  A Pietinalho; P Tukiainen; T Haahtela; T Persson; O Selroos
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

Review 4.  The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.

Authors:  T P van Staa; H G M Leufkens; C Cooper
Journal:  Osteoporos Int       Date:  2002-10       Impact factor: 4.507

Review 5.  Treatment of sarcoidosis.

Authors:  Catherine A Lazar; Daniel A Culver
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

6.  Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study.

Authors:  Amanda C Schutt; Wendy M Bullington; Marc A Judson
Journal:  Respir Med       Date:  2010-01-20       Impact factor: 3.415

7.  Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.

Authors:  D S Goldstein; M H Williams
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

8.  Epidemiological features of Turkish patients with sarcoidosis.

Authors:  B Musellim; O O Kumbasar; G Ongen; E Cetinkaya; H Turker; E Uzaslan; E Yenturk; O Uzun; L Saglam; G Celik; G Okumus; A N Annakkaya; G Altiay; L Tabak; A Sakar; G Kiter; S Erturan; H Turktas; E Yalniz; A Akkoclu; C Ogus; O T Dogan; M Ozkan; S Aktogu; I Uzel
Journal:  Respir Med       Date:  2009-02-01       Impact factor: 3.415

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.